Victory Capital Management Inc Avidity Biosciences, Inc. Transaction History

Victory Capital Management Inc

$95.7 Billion
Q4 2024

A detailed history of Victory Capital Management Inc transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 38,308 shares of RNA stock, worth $1.19 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

38,308

Previous 33,184 15.44%

Holding current value

$1.19 Million

Previous $1.52 Million 26.97%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 06, 2025	BUY	$29.08 - $52.5 $149,005 - $269,010	5,124 Added 15.44%	38,308 $1.11 Million
Q3 2024 Nov 05, 2024	BUY	$37.21 - $48.14 $422,966 - $547,207	11,367 Added 52.1%	33,184 $1.52 Million
Q2 2024 Aug 05, 2024	BUY	$22.73 - $40.85 $284,056 - $510,502	12,497 Added 134.09%	21,817 $891,000
Q1 2024 May 03, 2024	BUY	$9.16 - $25.52 $85,371 - $237,846	9,320 New	9,320 $237,000
Q3 2022 Nov 02, 2022	BUY	$15.46 - $23.43 $5,596 - $8,481	362 Added 1.86%	19,842 $324,000
Q2 2022 Aug 01, 2022	BUY	$11.18 - $20.5 $4,326 - $7,933	387 Added 2.03%	19,480 $283,000
Q1 2022 May 04, 2022	SELL	$14.2 - $23.78 $3,791 - $6,349	-267 Reduced 1.38%	19,093 $273,000
Q4 2021 Feb 07, 2022	SELL	$20.4 - $28.66 $64,321 - $90,364	-3,153 Reduced 14.01%	19,360 $460,000
Q3 2021 Nov 02, 2021	SELL	$18.16 - $25.21 $18.8 Million - $26.1 Million	-1,034,799 Reduced 97.87%	22,513 $554,000
Q2 2021 Aug 03, 2021	BUY	$19.62 - $29.26 $691,722 - $1.03 Million	35,256 Added 3.45%	1,057,312 $26.1 Million
Q1 2021 May 04, 2021	BUY	$20.28 - $28.15 $3.42 Million - $4.75 Million	168,764 Added 19.78%	1,022,056 $22.3 Million
Q4 2020 Feb 01, 2021	BUY	$24.73 - $35.12 $1.23 Million - $1.75 Million	49,925 Added 6.21%	853,292 $21.8 Million
Q3 2020 Nov 09, 2020	SELL	$23.35 - $35.94 $2.04 Million - $3.14 Million	-87,413 Reduced 9.81%	803,367 $22.6 Million
Q2 2020 Aug 07, 2020	BUY	$26.62 - $31.5 $23.7 Million - $28.1 Million	890,780 New	890,780 $25.2 Million

Others Institutions Holding RNA

# of Institutions

257

Shares Held

108M

Call Options Held

517K

Put Options Held

717K

View Full List

About Avidity Biosciences, Inc.

Ticker RNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,127,000
Market Cap $1.62B
Description
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...

More about RNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account

Victory Capital Management Inc Avidity Biosciences, Inc. Transaction History